Lessons learned from the use of COVID-19 convalescent plasma at Kaiser Permanente

BACKGROUND: In April 2020, the Mayo Clinic helped establish the US Food and Drug Administration Expanded Access Protocol for COVID-19 (coronavirus disease 2019) convalescent plasma (CCP). The effectiveness of CCP in the published literature is contradictory because some retrospective studies showed...

Descripción completa

Detalles Bibliográficos
Autores principales: Tse, Kevin, Chen, Qiaoling, Padilla, Ariadna, Martinez, Kenneth, Salazar, Alejandra, Aidikoff, Jennifer, Soliven, Stephanie, Sintef, Ann, Palmer-Toy, Darryl, Platz, Brian, Shafi, Hedyeh, Zemek, Allison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396439/
https://www.ncbi.nlm.nih.gov/pubmed/36051399
http://dx.doi.org/10.1016/j.jacig.2022.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396439/
https://www.ncbi.nlm.nih.gov/pubmed/36051399
http://dx.doi.org/10.1016/j.jacig.2022.07.003

Ejemplares similares